Answers are grounded in this paper and cite their sources.
Copper oxide nanoparticles (CuO NPs) were synthesized via a green, plant-mediated approach using aqueous leaf extract of Mentha spicata as a natural reducing and stabilizing agent. The formation of CuO NPs was confirmed by UV–visible spectroscopy, exhibiting a characteristic absorption peak around 290 nm. Fourier transform infrared spectroscopy (FTIR) analysis revealed the involvement of phytochemicals such as polyphenols and flavonoids in nanoparticle reduction and stabilization. X-ray diffraction (XRD ) analysis confirmed the formation of phase-pure monoclinic CuO, while scanning electron microscope (SEM) images showed predominantly spherical nanoparticles with sizes ranging from 60 to 80 nm. Elemental composition was verified using energy-dispersive X-ray and a zeta potential of −31.5 mV indicated good colloidal stability. The synthesized CuO NPs exhibited concentration-dependent biological activities. In vitro antioxidant activity showed an IC 50 of 152.53 μg/mL, while α-amylase inhibition demonstrated antidiabetic potential with an IC 50 of 163.38 μg/mL. Anti-inflammatory activity, assessed via protein denaturation assay, yielded an IC 50 of 149.94 μg/mL. Furthermore, the nanoparticles displayed significant cytotoxicity against A375 melanoma cells with an IC 50 of 54.9 μg/mL, while showing reduced toxicity toward L929 normal cells (IC 50 = 83.6 μg/mL), indicating moderate selectivity. Overall, the findings highlight the potential of Mentha spicata -mediated CuO NPs as stable and effective multifunctional nanomaterials for biomedical applications.
No takes yet. Share an insight, caveat, or question.
Shet et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: